Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Ye, Ting ^a,b   Zhen, Junhui ^b,c   Du, Yong ^d,e   Zhou, Jason K ^e   Peng, Ai ^f   Vaziri, Nosratola D ^g   Mohan, Chandra ^d,e   Xu, Yan ^h   Zhou, Xin J ^b,i,j  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITY OF HOUSTON   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h QINGDAO UNIVERSITY   (China)

ⁱ Renal Path Diagnostics Pathologists BioMedical Laboratories   (United States)

^j BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; EPIGALLOCATECHIN GALLATE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE PEROXIDASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT; CATECHIN; MITOGEN ACTIVATED PROTEIN KINASE; NFE2L2 PROTEIN, MOUSE; SIRT1 PROTEIN, MOUSE; SIRTUIN 1; TEA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG POTENCY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; MORTALITY; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHENOTYPE; PROTEIN URINE LEVEL; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SIGNAL TRANSDUCTION; 129 MOUSE; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DRUG EFFECTS; GLOMERULONEPHRITIS; KIDNEY; METABOLISM; PATHOLOGY; TEA;

MUS; ORYCTOLAGUS CUNICULUS;

ANIMALS; ANTIOXIDANTS; CATECHIN; GLOMERULONEPHRITIS; KIDNEY; MALE; MICE; MICE, 129 STRAIN; MITOGEN-ACTIVATED PROTEIN KINASES; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PPAR GAMMA; SIGNAL TRANSDUCTION; SIRTUIN 1; TEA;

EID: 84925708529     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119543     Document Type: Article

References (41)

1. Rogers TE, Rakheja D, Zhou XJ. Glomerular diseases associated with nephritic syndrome and/or rapidly progressive glomerulonephritis. In: Zhou XJ, Laszik Z, Nadasdy T, D'Agati V, Silva FG, editors. Silva's Diagnostic Renal Pathology. New York: Cambridge University Press; 2009. pp.178-228.
2. Moroni G, Ponticelli C. Rapidly progressive crescentic glomerulonephritis: early treatment is a must. Autoimmun Rev 2014; 13:723-729. doi: 10.1016/j.autrev.2014.02.007 PMID: 24657897
3. Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med. 2010; 363:343-54. doi: 10.1056/NEJMoa0910500 PMID: 20660402
4. Kalluri R, Wilson CB, Weber M, Gunwar S, Chonko AM, Neilson EG, et al. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Good-pasture syndrome. J Am Soc Nephrol. 1995; 6:1178-1185. PMID: 8589284
5. Turner JE. Glomerulonephritis therapy:is there a role for green tea? Kidney Int 2011; 80:563-4. doi: 10.1038/ki.2011.173 PMID: 21878951
6. Rehan A, Johnson KJ, Wiggins RC, Kunkel RG, Ward PA. Evidence for the role of oxygen radicals in acute nephrotoxic nephritis. Lab Invest. 1984; 51:396-403. PMID: 6090809
7. Sykiotis GP, Bohmann D. Stress-activated cap'n'collar transcription factors in aging and human disease. Sci Signal 2010; 3:re3 doi: 10.1126/scisignal.3112re3 PMID: 20215646
8. Copple IM, Goldring CE, Kitteringham NR, Park BK. The keap1-nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity. Handb Exp Pharmacol. 2010; 196:233-266. doi: 10.1007/978-3-642-00663-0-9 PMID: 20020265
9. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997; 236:313-322. PMID: 9240432
10. Hagiya Y, Adachi T, Ogura S, An R, Tamura A, Nakagawa H, et al. Nrf2-dependent induction of human ABC transporter ABCG2 and heme oxygenase-1 in HepG2 cells by photoactivation of porphyrins: biochemical implications for cancer cell response to photodynamic therapy. J Exp Ther Oncol. 2008; 7:153-167. PMID: 18771089
11. Kim HJ, Vaziri ND. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol. 2010; 298:F662-71. doi: 10.1152/ajprenal.00421.2009 PMID: 20007347
12. Kim HJ, Sato T, Rodriguez-Iturbe B, Vaziri ND. Role of intra-renal angiotensin system activation, oxidative stress, inflammation and impaired Nrf2 activity in the progression of focal glomerulosclerosis. J Pharmacol Exp Ther. 2011; 337:583-90. doi: 10.1124/jpet.110.175828 PMID: 21357516
13. Yoh K, Itoh K, Enamoto A, Hirayama A, Yamaguchi N, Kobayashi M, et al. Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int 2001; 60:1343-1353. PMID: 11576348
14. Kim H, QUan MJ, Kim J. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphonel, epigallocatechin-3-gallate. Redox Biol 2014; 2:187-195 doi: 10.1016/j.redox.2013.12.022 PMID: 24494192
15. Sahin K, Tuzcu M, Gencoglu H, Dogukan A, TimurkanM, Sahin N, et al. Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci. 2010; 87:240-245. doi: 10.1016/j.lfs.2010.06.014 PMID: 20619277
16. Tsai PY, Ka SM, Chang JM, Chen HC, Shui HA, LI CY, et al. Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation. Free Radic Biol Med. 2011; 51:744-754. doi: 10.1016/j.freeradbiomed.2011.05.016 PMID: 21641991
17. Peng A, Ye T, Rakheja D, Tu Y, Wang T, Du Y, et al. Green tea polyphenol, epigallocatechin-3-gallate (EGCG), ameliorates experimental immune-mediated glomerulonephritis. Kidney Int. 2011; 80:601-611. doi: 10.1038/ki.2011.121 PMID: 21544063
18. Lu H, Zhen J, Wu T, Peng A, Ye T, Wang T, et al. Superoxide dismutase mimetic drug tempol aggravates anti-GBM antibody induced glomerulonephritis in mice. Am J Physiol Renal Physiol. 2010; 299:445-452.
19. Xie C, Sharma R, Wang H, Zhou XJ, Mohan C. Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol. 2004; 172:5047-5055. PMID: 15067087
20. Goodin MG, Fertuck KC, Zacharewski TR, Rosengren RJ. Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro. Toxicol Sci. 2002; 69:354-61. PMID: 12377984
21. Zinellu A, Caria MA, Tavera C, Sotgia S, Chessa R, Deiana L, et al. Plasma creatinine and creatine quantification by capillary electrophoresis diode array detector. Anal Biochem. 2005; 342:186-193. PMID: 15927140
22. Zhou XJ, Laszik Z, Wang XQ, Silva FG, Vaziri ND. Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab Invest. 2000; 80:1905-1914. PMID: 11140702
23. Zhen J, Lu H, Wang XQ, Vaziri ND, Zhou XJ. Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am J Hypertens. 2008; 21:28-34. PMID: 18091741
24. Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol. 2010; 80:1895-1903. doi: 10.1016/j.bcp.2010.07.014 PMID: 20643109
25. Yeligar SM, Machida K, Kalra VK. Ethanol-induced HO-1 and NQO1 are differentially regulated by HIF-1alpha and Nrf2 to attenuate inflammatory cytokine expression. J Biol Chem. 2010; 285:35359-73. doi: 10.1074/jbc.M110.138636 PMID: 20833713
26. Jaiswal AK. Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Radic Biol Med. 2000; 29:254-262. PMID: 11035254
27. Yu M, Li H, Liu Q, Liu F, Tang L, Li C, et al. Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. Cellular Signal. 2011; 23:883-892. doi: 10.1016/j.cellsig.2011.01.014 PMID: 21262351
28. Sandberg M, Patil J, D'Angelo B, Weber SG, Mallard C. NRF2-regulation in brain health and disease: implication of cerebral inflammation. Neuropharmacology 2014; 79:298-306. doi: 10.1016/j.neuropharm.2013.11.004 PMID: 24262633
29. Hao CM, Haase VH. Sirtuins and their relevance to the kidney. J Am Soc Nephrol. 2010; 21:1620-1627. doi: 10.1681/ASN.2010010046 PMID: 20595677
30. Sarafidis PA, Bakris GL. Protection of the kidney by thiazolidinediones: an assessment from bench to bedside. Kidney Int. 2006; 70:1223-33. PMID: 16883325
31. Haraguchi K, Shimura H, Onaya T. Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR)gamma activators. Clin Exp Nephrol. 2003; 7:27-32. PMID: 14586740
32. Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int. 2001; 59:1899-910. PMID: 11318962
33. Miyazaki Y, Cersosimo E, Triplitt C, DeFronzo RA. Rosiglitazone decreases albuminuria in type 2 diabetic patients. Kidney Int. 2007; 72:1367-1373. PMID: 17805239
34. Kincaid-Smith P, Fairley KF, Farish S, Best JD, Proietto J. Reduction of proteinuria by rosiglitazone in non-diabetic renal disease. Nephrology (Carlton). 2008; 13:58-62. doi: 10.1111/j.1440-1797.2007.00903.x PMID: 18199105
35. Aprahamian T, Bonegio RG, Richez C, Yasuda K, Chiang LK, Sato K, et al. The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin. J Immunol. 2009; 182:340-346. PMID: 19109165
36. Cho HY, Gladwell W, Wang X, Chorley B, Bell D, Reddy SP, et al. Nrf2-regulated PPAR{gamma} expression is critical to protection against acute lung injury in mice. Am J Respir Crit Care Med. 2010; 182:170-182. doi: 10.1164/rccm.200907-1047OC PMID: 20224069
37. Wu T, Qin X, Kurepa Z, Kumar KR, Liu K, Kanta H, et al. Shared signaling networks activate in B cells isolated from genetically distinct mouse models of lupus. J. Clin Invest. 2007; 117:2186-2196. PMID: 17641780
38. Wu T, Ye Y, Min SY, Zhu J, Khobahy E, Zhou JK, et al. Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid. Arthritis Rheumatol. 2014; 66:3129-3139. doi: 10.1002/art.38782 PMID: 25047252
39. Afaq F, Adhami VM, Ahmad N, Mukhtar H. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate. Oncogene. 2003; 22:1035-1044. PMID: 12592390
40. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res. 2006; 66:2500-5. PMID: 16510563
41. Peairs A, Dai R, Gan L, Shimp S, Rylander MN, Li L, et al. Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells. Cell Mol Immunol. 2010; 7:123-132. doi: 10.1038/cmi.2010.1 PMID: 20140007